These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 9012651)

  • 21. Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and adp-stimulated human platelets.
    Barre DE
    Front Biosci; 2004 Jan; 9():404-10. PubMed ID: 14766377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
    J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, and abciximab on in vitro antiplatelet effect and binding properties.
    Suzuki K; Sato K; Kamohara M; Kaku S; Kawasaki T; Yano S; Iizumi Y
    Biol Pharm Bull; 2002 Aug; 25(8):1006-12. PubMed ID: 12186399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb.
    Kosugi S; Tomiyama Y; Honda S; Kato H; Kiyoi T; Kashiwagi H; Kurata Y; Matsuzawa Y
    Blood; 2001 Sep; 98(6):1819-27. PubMed ID: 11535516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized low-density lipoprotein inhibits the binding of monoclonal antibody to platelet glycoprotein IIB-IIIA.
    Szuwart T; Zhao B; Fritsch A; Mertens K; Dierichs R
    Thromb Res; 1999 Oct; 96(2):85-90. PubMed ID: 10574585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotational mobility of the fibrinogen receptor glycoprotein IIb/IIIa or integrin alpha IIb beta 3 in the plasma membrane of human platelets.
    González-Rodríguez J; Acuña AU; Alvarez MV; Jovin TM
    Biochemistry; 1994 Jan; 33(1):266-74. PubMed ID: 7506929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH; Wall CD; White MM; Jennings LK
    Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPIIIa(90-102) and GPIIIa(631-653) epitopes as markers of conformational changes occurring during the activation of the glycoprotein IIb/IIIa complex.
    Niewiarowska J; Cierniewski CS
    Eur J Biochem; 1994 Sep; 224(3):803-9. PubMed ID: 7523118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
    Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
    Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteolytic susceptibility of platelet low density lipoprotein receptor.
    Pedreño J; Fernández R
    Lipids; 1995 Oct; 30(10):927-33. PubMed ID: 8538380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
    Sloan SM; Brown EB; Liu Q; Frojmovic MM
    Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
    Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
    Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
    Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL
    Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Val193Met mutation in GPIIIa results in a GPIIb/IIIa receptor with a constitutively high affinity for a small ligand.
    Fullard J; Murphy R; O'Neill S; Moran N; Ottridge B; Fitzgerald DJ
    Br J Haematol; 2001 Oct; 115(1):131-9. PubMed ID: 11722423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two human antibodies reacting with different epitopes on integrin beta 3 of platelets and endothelial cells.
    Jallu V; Diaz-Ricart M; Ordinas A; Pico M; Vezon G; Nurden AT
    Eur J Biochem; 1994 Jun; 222(3):743-51. PubMed ID: 7517865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.